Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Cancer Cell International

Figure 4

From: Inhibition of proliferation and migration of luminal and claudin-low breast cancer cells by PDGFR inhibitors

Figure 4

Masitinib inhibits migration of MCF-7 and MDA-MB-231 cells. The bar graph represents the percentage of the wound closed from 3 independent scratch wound assays and is expressed as mean ± SEM when treated with (grey bar) 5 μM or (black bar) 10 μM of Masitinib. Masitinib was added to the cells immediately after the creation of the wound and wounds were evaluated at 48 hrs after inhibitor administration. *Indicates values that were significantly different (p < 0.05) from the DMSO control.

Back to article page